The Europe Nanotechnology in Medical Devices Market is currently estimated at USD 1618 Million in 2018 and is poised to reach USD 2940 Million by 2023 with a growth rate of 12.7%. The significant growth rate is attributed to the technological advancements, rising prevalence of aging population resulting in increasing incidences of diseases. There is an increased optimism about the ability of nanotechnology based medical devices to reform the healthcare industry.
Nanotechnology involves the use of nano-robots to repair at the cellular level involving the dimension that are tiny fractions of the human hair. With many nanotechnology based applications at various stages of testing, it offers exciting opportunities and is believed to revolutionise the treatment for human body in the future.
The market is driven by a list of factors that include rising investments in research and development of nanotechnology with international collaboration, rising aging population, increasing awareness, growing expenditure with increased availability of insurance coverage and reimbursement. However, there are few factors hampering the growth of the market that include high cost involving nanotechnology devices and stringent regulatory policies.
The Europe nanotechnology in medical devices is categorised based on the type of the product as medical textile and wound dressing, biochips, implantable material, active implantable material and others. The implantable materials is sub-divided into dental filling and bone restorative material while the active implantable material is again divided into rental implants, cardio rhythm management and hearing aid devices. On the basis of applications the market is segmented as research, therapeutics and diagnostics. Based on the region, the geographical region is segmented as United Kingdoms, Germany, France, Italy and Spain.
The nanotechnology in medical device market is dominated by the players like Acusphere, Inc., AMAG Pharmaceuticals, 3M Company, St. Jude Medical, Inc., Affymetrix, Inc., PerkinElmer, Inc. Stryker Corporation, Starkey Hearing Technologies and Smith & Nephew, Inc.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modeling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 By Product
5.1.1 Implantable Material
5.1.1.1 Bone Restorative Material
5.1.1.2 Dental Filling Material
5.1.2active implantable material
5.1.2.1 Hearing Aid Devices
5.1.2.2 Cardio Rhythm Management Devices
5.1.3 Biochips
5.1.4 Medical Textile and Wound Dressing
5.1.5 Others
5.2 By Application
5.2.1 Diagnostics
5.2.2 Therapeutics
5.2.3 Research
6.1 U.K
6.2 Spain
6.3 Germany
6.4 Italy
6.5 France
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Acusphere, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 AMAG Pharmaceuticals
8.3 Stryker Corporation
8.4 3M Company
8.5 St. Jude Medical, Inc.
8.6 Affymetrix, Inc.
8.7 Smith & Nephew, Inc.
8.8 PerkinElmer, Inc.
8.9 Starkey Hearing Technologies
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
